Evidence map›Paper›PMID 22162710›Full record

ReviewClinical & developmental immunology2011

Immune microenvironment in colorectal cancer: a new hallmark to change old paradigms.

Luis de la Cruz-Merino, Fernando Henao Carrasco, David Vicente Baz, Esteban Nogales Fernández, Juan José Reina Zoilo, Manuel Codes Manuel de Villena, Enrique Grande Pulido

Abstract readReview
In one paragraph

Review in Clinical & developmental immunology, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. Article
  9. Fates of CD8+ T cells in Tumor Microenvironment.Computational and structural biotechnology journal · 2019
    Review
  10. Article
  11. Article
  12. Review
  13. Article
  14. Clinical significance of immunotherapy with combined three kinds of cells for operable colorectal cancer.Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine · 2015
    Article
  15. Enhancement of T cell recruitment and infiltration into tumours.Clinical and experimental immunology · 2014
    Review
  16. Article
  17. Article
  18. Changes of T cells and cytokines TGF-β1 and IL-10 in mice during liver metastasis of colon carcinoma: implications for liver anti-tumor immunity.Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract · 2013
    Article
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Luis de la Cruz-MerinoClinical Oncology Department, Hospital Universitario Virgen Macarena, Avenida Dr. Fedriani s/n, 41009 Sevilla, Spain. lucme12@yahoo.es
Fernando Henao Carrasco
David Vicente Baz
Esteban Nogales Fernández
Juan José Reina Zoilo
Manuel Codes Manuel de Villena
Enrique Grande Pulido

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Impact of immune microenvironment in prognosis of solid tumors has been extensively studied in the last few years. Specifically in colorectal carcinoma, increased knowledge of the immune events around these tumors and their relation with clinical outcomes have led to consider immune microenvironment as one of the most important prognostic factors in this disease. In this review we will summarize and update the current knowledge with respect to this intriguing and complex new hallmark of cancer, paying special attention to infiltration by T-infiltrating lymphocytes and their subtypes in colorectal cancer, as well as its eventual clinical translation in terms of long-term prognosis. Finally, we suggest some possible investigational approaches based on combinatorial strategies to trigger and boost immune reaction against tumor cells.

Indexed as

Antigen-Presenting CellsAntineoplastic AgentsB7-1 AntigenBiomarkers, TumorCarcinomaColorectal NeoplasmsCTLA-4 AntigenHumansLymphocytes, Tumor-InfiltratingMicrosatellite InstabilityPrognosisT-Lymphocytes, CytotoxicT-Lymphocytes, RegulatoryTumor MicroenvironmentAntineoplastic AgentsB7-1 AntigenBiomarkers, TumorCTLA-4 Antigen

Identifiers

PMID22162710
PMCPMC3226426

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.